Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase

被引:133
作者
Darvesh, Sultan [1 ,2 ,3 ]
Darvesh, Katherine V. [3 ]
McDonald, Robert S. [3 ]
Mataija, Diane [3 ]
Walsh, Ryan [2 ]
Mothana, Sam [3 ]
Lockridge, Oksana [4 ]
Martin, Earl [3 ]
机构
[1] Dalhousie Univ, Dept Med Neurol, Halifax, NS, Canada
[2] Dalhousie Univ, Dept Anat & Neurobiol, Halifax, NS, Canada
[3] Mt St Vincent Univ, Dept Chem, Halifax, NS B3M 2J6, Canada
[4] Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE USA
关键词
D O I
10.1021/jm8002075
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Most carbamates are pseudoirreversible inhibitors of cholinesterases. Phenothiazine carbamates exhibit this inhibition of acety1cholinesterase but produce reversible inhibition of butyrylcholinesterase, suggesting that they do not form a covalent bond with the catalytic serine. This atypical inhibition is attributable to pi-pi interaction of the phenothiazine moiety with F329 and Y332 in butyrylcholinesterase. These residues are in a helical segment, referred to here as the E-helix because it contains E325 of the catalytic triad. The involvement of the E-helix in phenothiazine carbamate reversible inhibition of butyrylcholinesterase is confirmed using mutants of this enzyme at A328, F329, or Y332 that show typical pseudoirreversible inhibition. Thus, in addition to various domains of the butyrylcholinesterase active site gorge, such as the peripheral anionic site and the a-cationic site of the Omega-loop, the E-helix represents a domain that could be exploited for development of specific inhibitors to treat dementias.
引用
收藏
页码:4200 / 4212
页数:13
相关论文
共 35 条
  • [1] [Anonymous], 2006, SPARTAN 06
  • [2] The Protein Data Bank
    Berman, HM
    Westbrook, J
    Feng, Z
    Gilliland, G
    Bhat, TN
    Weissig, H
    Shindyalov, IN
    Bourne, PE
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 235 - 242
  • [3] Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]
  • [4] CLARKE D, 1978, J CHEM SOC P2, V10, P1103
  • [5] BASICALLY SUBSTITUTED DERIVATIVES OF PHENOTHIAZINE-10-CARBOXYLIC ACID
    DAHLBOM, R
    [J]. ACTA CHEMICA SCANDINAVICA, 1953, 7 (06): : 879 - 884
  • [6] Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives
    Darvesh, S
    McDonald, RS
    Penwell, A
    Conrad, S
    Darvesh, KV
    Mataija, D
    Gomez, G
    Caines, A
    Walsh, R
    Martin, E
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (01) : 211 - 222
  • [7] Neurobiology of butyrylcholinesterase
    Darvesh, S
    Hopkins, DA
    Geula, C
    [J]. NATURE REVIEWS NEUROSCIENCE, 2003, 4 (02) : 131 - 138
  • [8] Inhibition of human cholinesterases by drugs used to treat Alzheimer disease
    Darvesh, S
    Walsh, R
    Kumar, R
    Caines, A
    Roberts, S
    Magee, D
    Rockwood, K
    Martin, E
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2003, 17 (02) : 117 - 126
  • [9] Butyrylcholinesterase and cognitive function
    Darvesh, S
    MacKnight, C
    Rockwood, K
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2001, 13 (04) : 461 - 464
  • [10] Butyrylcholinesterase-mediated enhancement of the enzymatic activity of trypsin
    Darvesh, S
    Kumar, R
    Roberts, S
    Walsh, R
    Martin, E
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2001, 21 (03) : 285 - 296